These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 2379424)
21. Hepatic artery flow and propranolol metabolism in perfused cirrhotic rat liver. Le Couteur DG; Hickey H; Harvey PJ; Gready J; McLean AJ J Pharmacol Exp Ther; 1999 Jun; 289(3):1553-8. PubMed ID: 10336552 [TBL] [Abstract][Full Text] [Related]
22. The effect of mechanically enhancing portal venous inflow on hepatic oxygenation, microcirculation, and function in a rabbit model with extensive hepatic fibrosis. Jiao LR; Seifalian AM; Habib N; Davidson BR Hepatology; 1999 Jul; 30(1):46-52. PubMed ID: 10385637 [TBL] [Abstract][Full Text] [Related]
23. Neutral endopeptidase (EC 3.4.24.11) in cirrhotic liver: a new target to treat portal hypertension? Sansoè G; Aragno M; Mastrocola R; Restivo F; Mengozzi G; Smedile A; Rosina F; Danni O; Parola M; Rizzetto M J Hepatol; 2005 Nov; 43(5):791-8. PubMed ID: 16085334 [TBL] [Abstract][Full Text] [Related]
24. Changes in blood flow, portal pressure and shunting during the development of cirrhosis in response to beta-blockade. McLaren M; Braye S; Fleming J; Karran S; Taylor I Gut; 1987 Jun; 28(6):663-7. PubMed ID: 2887489 [TBL] [Abstract][Full Text] [Related]
25. Development of portahepatic venous shunts and cirrhosis in carbon tetrachloride poisoning in rats. Hase T Am J Pathol; 1968 Jul; 53(1):83-98. PubMed ID: 5654526 [No Abstract] [Full Text] [Related]
26. Increased sinusoidal resistance is responsible for the basal state and endothelin-induced venoconstriction in perfused cirrhotic rat liver. Shibamoto T; Kamikado C; Koyama S Pflugers Arch; 2008 Jun; 456(3):467-77. PubMed ID: 18193271 [TBL] [Abstract][Full Text] [Related]
27. Liposome-mediated gene transfer of endothelial nitric oxide synthase to cirrhotic rat liver decreases intrahepatic vascular resistance. Zhang ZQ; Qiu JF; Luo M; Sun YW; Zhao G; Chen W; Liu H; Wu ZY J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e487-93. PubMed ID: 18070013 [TBL] [Abstract][Full Text] [Related]
29. Nitroflurbiprofen, a nitric oxide-releasing cyclooxygenase inhibitor, improves cirrhotic portal hypertension in rats. Laleman W; Van Landeghem L; Van der Elst I; Zeegers M; Fevery J; Nevens F Gastroenterology; 2007 Feb; 132(2):709-19. PubMed ID: 17258737 [TBL] [Abstract][Full Text] [Related]
30. Normal increase in glucose output by portal noradrenaline and glucagon but not nerve stimulation with enhanced portal resistance, not only in micronodular but also in intermediate thioacetamide cirrhotic livers. Gardemann A; Zimmermann T; Machnik G; Dargel R; Jungermann K Hepatology; 1993 Dec; 18(6):1544-5. PubMed ID: 8244284 [No Abstract] [Full Text] [Related]
31. The eNOS cofactor tetrahydrobiopterin improves endothelial dysfunction in livers of rats with CCl4 cirrhosis. Matei V; Rodríguez-Vilarrupla A; Deulofeu R; Colomer D; Fernández M; Bosch J; Garcia-Pagán JC Hepatology; 2006 Jul; 44(1):44-52. PubMed ID: 16799985 [TBL] [Abstract][Full Text] [Related]
32. Contrast-enhanced ultrasound for quantitative assessment of portal pressure in canine liver fibrosis. Zhai L; Qiu LY; Zu Y; Yan Y; Ren XZ; Zhao JF; Liu YJ; Liu JB; Qian LX World J Gastroenterol; 2015 Apr; 21(15):4509-16. PubMed ID: 25914459 [TBL] [Abstract][Full Text] [Related]
33. Measurement of intrahepatic pressure as an index of hepatic sinusoidal pressure. Saito M; Ohnishi K; Terabayashi H; Tanaka H; Iida S; Nomura F Am J Gastroenterol; 1987 Oct; 82(10):1057-61. PubMed ID: 3661515 [TBL] [Abstract][Full Text] [Related]
34. Presinusoidal and proximal intrasinusoidal confluence of hepatic artery and portal vein in rat liver: functional evidence by orthograde and retrograde bivascular perfusion. Watanabe Y; Püschel GP; Gardemann A; Jungermann K Hepatology; 1994 May; 19(5):1198-207. PubMed ID: 8175142 [TBL] [Abstract][Full Text] [Related]
35. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats. Niederberger M; Ginés P; Martin PY; Tsai P; Morris K; McMurtry I; Schrier RW Hepatology; 1996 Oct; 24(4):947-51. PubMed ID: 8855203 [TBL] [Abstract][Full Text] [Related]
36. An intravital fluorescence microscopic study of hepatic microvascular and cellular derangements in developing cirrhosis in rats. Vollmar B; Siegmund S; Menger MD Hepatology; 1998 Jun; 27(6):1544-53. PubMed ID: 9620325 [TBL] [Abstract][Full Text] [Related]
37. Simultaneous treatment of portal hypertension and hepatic cirrhosis by splenohepatoplasty. Vara-Thorbeck R; Maza-Inza J Surg Gynecol Obstet; 1978 Sep; 147(3):391-6. PubMed ID: 684592 [TBL] [Abstract][Full Text] [Related]
38. [The cellular mechanisms of the regeneration of the cirrhotic liver in rats. I. The correlation of the processes of cellular proliferation, polyploidization and hypertrophy after the cessation of chronic exposure to carbon tetrachloride]. Sakuta GA; Kudriavtsev BN Tsitologiia; 1996; 38(11):1158-70. PubMed ID: 9082615 [TBL] [Abstract][Full Text] [Related]
39. Alterations of hepatic sinusoids in liver cirrhosis: their involvement in the pathogenesis of portal hypertension. Oda M; Azuma T; Nishizaki Y; Kaneko K; Komatsu H; Tsukada N; Watanabe N; Nakamura M; Tsuchiya M J Gastroenterol Hepatol; 1989; 4 Suppl 1():111-3. PubMed ID: 2519023 [No Abstract] [Full Text] [Related]
40. [Sinusoidal liver cells of the normal rat and during the development of experimental cirrhosis]. Kostyrev OA; Borisova GI Arkh Patol; 1968; 30(1):27-32. PubMed ID: 5650345 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]